NCT04754906 Analysis of Motor Skills in Subjects Aged 55 and Over: the Role of Cognitive Abilities for Planning Movement.
| NCT ID | NCT04754906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire Dijon |
| Condition | Mild Cognitive Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 684 participants |
| Start Date | 2021-01-25 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 684 participants in total. It began in 2021-01-25 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Falling is an event that is more frequent and severe in older age. It can lead to a loss of autonomy and a decrease in quality of life. It is therefore important to understand this phenomenon in order to better prevent it. Among the multiple risk factors associated with falling, recent research has shown a link between the decline in cognitive abilities (i.e., the mental processes that form our knowledge, such as memory) and the risk of falling. However, the impact of this cognitive decline on motor skills is still poorly understood. The purpose of this research is to study how the changes induced by aging affect motor skills. This would make it possible to take a new look at the phenomenon of falls occurring in the elderly and, in the long term, to improve the prevention and rehabilitation.
Eligibility Criteria
Inclusion Criteria: 1. Neurotypical subjects group: * Person aged 18 to 40 years * Person who has given oral consent * Affiliated to national health insurance * Right-handed person 2. Group of elderly neurotypical subjects: * Person over 55 years of age * Person who has given oral consent * Affiliated to national health insurance * No cognitive problems (MMSE score \>26) * Right-handed person 3. Elderly mild cognitive disorder subject group: * Person over 55 years of age * Person who has given oral consent * Diagnosis of Mild Cognitive Disorder made by a neurologist at the Centre Mémoire Ressources et Recherche (CMRR) of the University Hospital of Dijon, following the recommendations of the National Institute for Aging and Alzheimer's Association (Albert et al., 2011) This diagnosis is based on psychometric tests, brain imaging and the evolution of cognitive disorders, including an MMSE test. * Right-handed person Exclusion Criteria: * Neurological or psychiatric history with the exception of the TCL group. * Follow-up of drug treatment in the last three months that may affect cognitive and/or motor skills. * Received a shoulder prosthesis on the dominant side. * Received a hip and/or knee replacement less than a year ago. * Disabling joint disease of the hip or knee shoulder * Protected adults (curatorship, guardianship) * Person deprived of their liberty b judicial or administrative decision * Pregnant, parturient or breastfeeding woman * Major unable to consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04754906 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mild Cognitive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04754906 currently recruiting?
Yes, NCT04754906 is actively recruiting participants. Contact the research team at patrick.manckoundia@chu-dijon.fr for enrollment information.
Where is the NCT04754906 trial being conducted?
This trial is being conducted at Dijon, France.
Who is sponsoring the NCT04754906 clinical trial?
NCT04754906 is sponsored by Centre Hospitalier Universitaire Dijon. The trial plans to enroll 684 participants.